Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03150511 · ClinicalTrials.gov registry record · Phase 2
Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
A Phase 2 study of Peripheral Nerve Injuries, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT03150511 is a Phase 2 study of Peripheral Nerve Injuries that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 36 participants, below the 457-participant average among 8 other Peripheral Nerve Injuries trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03150511, a Phase 2 study of Peripheral Nerve Injuries, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this clinical trial is to evaluate the efficacy of tesamorelin as a therapy for peripheral nerve injuries. The investigators hypothesize that treatment with tesamorelin will result in faster and more substantial recovery of motor and sensory function following surgical repair of injured peripheral nerves. Patients with upper extremity nerve injuries will be randomly assigned to receive either tesamorelin treatment or no treatment. Assessments for nerve regeneration, muscle function, and sensation will be conducted every three months for a total of 12 months. Outcomes in patients receiving tesamorelin will be compared to those in the untreated group to determine the effectiveness of tesamorelin as a therapeutic intervention for nerve injuries.
Conditions Studied
Interventions
- DRUG Tesamorelin 2 Milligrams (MG)
Study Locations (1)
Maryland
- Sami Tuffaha - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2027-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03150511
The ClinicalTrials.gov registry entry for NCT03150511 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 457-participant average among 8 other Peripheral Nerve Injuries trials with a reported enrollment target (92% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Nerve Injuries appearing as the primary indexed condition, and to 1 intervention - of which Tesamorelin 2 Milligrams (MG) is the first listed.
NCT03150511 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03150511 about?
NCT03150511 is a clinical study titled "Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury". The aim of this clinical trial is to evaluate the efficacy of tesamorelin as a therapy for peripheral nerve injuries. The investigators hypothesize that treatment with tesamorelin will result in faster and more substantial recovery of motor and sensory function following surgical repair of injured p...
What is the current status of trial NCT03150511?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2018-06-01. Estimated completion is 2027-12.
What conditions does trial NCT03150511 study?
This clinical trial studies the following conditions: Peripheral Nerve Injuries.
What interventions are being tested in trial NCT03150511?
The interventions under investigation include: Tesamorelin 2 Milligrams (MG) (DRUG).
Who is sponsoring clinical trial NCT03150511?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03150511 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Nerve Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)
RECRUITING · Phase 2
-
Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries
COMPLETED · Phase 2
-
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
RECRUITING · NA
-
Promoting Healing of Injured Nerves With Electrical Stimulation Therapy
RECRUITING · NA
-
Upper Extremity Functional Electrical Stimulation (FES) for Restoration of Upper Extremity Function After Spinal Cord Injury (SCI)
RECRUITING · NA
-
A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.